Breaking Business News: Sun Pharma to Buy Remaining Stake in Taro
Sun Pharma is picking up all the shares in Taro Pharmaceuticals that it doesn’t already own. The two companies have entered into a definitive merger agreement in which Sun Pharma, Taro’s controlling shareholder, has agreed to acquire all of the outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or […]
Validated: A New PROM to Assess Disease Control in Chronic Prurigo
Chronic prurigo (CPG), including prurigo nodularis, is difficult to treat and dramatically affects quality of life. So, how can dermatologists best assess whether a treatment working or not? Enter the Prurigo Control Test, which has passed muster and may be the first patient-reported outcome measure (PROM) to determine disease control and guide treatment decisions in […]
DermaSensor Empowers Internists to Diagnose Skin Cancer: What Will This Mean for Derms and Patients?
The U.S Food and Drug Administration (FDA) has cleared DermaSensor for skin cancer detection in primary care, the Company reports. Wireless and handheld, DermaSensor’s AI-powered spectroscopy technology non-invasively evaluates cellular and subcellular characteristics of a lesion, providing an immediate and objective result using an FDA-cleared algorithm. The FDA pivotal study of more than 1,000 patients, showed […]
Practice-Changing Melanoma Research From ECOG-ACRIN Receives the 2023 Paper of the Year Distinction from the Journal of Clinical Oncology
And the 2023 Paper of the Year distinction by the Journal of Clinical Oncology goes to … a team of melanoma researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). The recognition is for the results of the DREAMseq randomized phase 3 clinical trial. DREAMseq (EA6134) showed an optimal treatment sequence for combination therapy in patients with advanced melanoma with […]